News Center
Home/News
News Center / Company news
Congratulations to Lunarsun on the Successful Approval of Tigecycline for Injection!
2024.09.14

Beijing Lunarsun Pharma is excited to announce that Tigecycline for Injection was approved for production on September 14, 2024.

Approval Number: H20244853

We look forward to discussing potential partnerships with interested pharmaceutical manufacturers.

Prev：Congratulations to Lunarsun on the Successful Approval of Famotidine Injection!
Return
More
Our new website has launched on December 26, 2024.
2024.12.26
Congratulations to Lunarsun on the Successful Approval of Tigecycline for Injection!
2024.09.14
Congratulations to Lunarsun on the Successful Approval of Famotidine Injection!
2024.08.05

Copyright(C)2024,Beijing Lunarsun Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle 31fabu Copyright Notice